Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
ROCKVILLE, Md., Jan. 23, 2024 /PRNewswire/ — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced that Dr. Anatoly Dritschilo, Chief Executive Officer, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners 2024 Investor Select Conference, taking place virtually on February 1, 2024.
Related news for (SHPH)
- Today’s Top Performers: MoBot’s Market Review 07/15/25 05:00 PM
- MoBot’s Stock Market Highlights – 07/15/25 04:00 PM
- Today’s Top Performers: MoBot’s Market Review 05/12/25 05:00 AM
- MoBot alert highlights: NASDAQ: NXTT, NASDAQ: SHPH, NASDAQ: BTCS, NASDAQ: TAOP, NASDAQ: JYD (05/12/25 04:00 AM)
- Today’s Sizzling Stocks to Trade – SYTA, WBUY, SHPH, SRXH, NVVE, and ZKIN Deliver Explosive News-Driven Moves